Fortis Healthcare shares gain as analysts see up to 25% upside post solid Q3

1 hour ago

HomeMarket NewsFortis Healthcare shares gain as analysts see up to 25% upside post solid Q3

Brokerages UBS and Citi have 'buy' recommendations on the Fortis Healthcare stock while JPMorgan has an 'overweight' rating. 

2 Min Read

Shares of Fortis Healthcare Ltd. gained on Tuesday, February 17, as analysts are positive on the stock and have indicated up to a 25% upside.

Brokerages UBS and Citi have 'buy' recommendations on the Fortis Healthcare stock while JPMorgan has an 'overweight' rating.


UBS

UBS has a 'buy' rating on the stock with a target price of ₹1,150 per share.

It said the company reported a healthy performance in the third quarter and the trend is likely to continue.

It added that it was a good quarter, with revenue increasing 17.5% and earnings before interest, tax, depreciation and amortisation (EBITDA) increasing 35%.

UBS said the potential infusion by its parent company IHH and capacity expansion will support Fortis' growth.

Citi

Citi has a 'buy' recommendation on Fortis with a price target of ₹1,120 per share, an upside of 22% from its previous close of ₹917 apiece.

It said the company reported a strong third quarter and is confident of sustaining its momentum.

Citi said the catalysts include:


Existing hospitals showing strong traction.
Brownfield expansions at high-occupancy facilities set to improve margin.
Newly-acquired facilities performing well.
Parent company IHH remaining open to further equity infusion.

JPMorgan

JPMorgan has an 'overweight' rating on Fortis Healthcare with a price target of ₹1,150 per share.

It said the company delivered a strong third quarter with revenues in-line and a notable margin beat.

Hospitals witnessed 19% revenue growth and 29% EBITDA growth, driven by higher occupied beds and improved margins, it said.

The company's diagnostics business grew 7% in revenue, but EBITDA surged 76% on margin gains from a greater share of specialised and wellness portfolios, JPMorgan said.

It added that bed expansion is on track, with new units ramping up well without creating much of a drag on occupancy.

Fortis' management reiterated IHH's commitment to Fortis as its 'growth engine' for India and outlined plans to increase its stake from 31% after the current cooling period ends.

Of the 17 analysts who have coverage on the stock, 14 have a 'buy' rating and three  have a 'hold' rating.

Fortis shares were up 1.5% at ₹929.4 apiece just after market open on Tuesday. The stock has gained 51.5% in the past year.

Also Read: L&T shareholders may get a special dividend, CLSA says; sees stock at ₹4,842

First Published: 

Feb 17, 2026 9:17 AM

IST

Read Full Article at Source